DOSSIER · 13F-HR · Q4 2025

Opaleye Management Inc.

Opaleye's family office based in Chicago, IL $758M in tracked AUM across 54 positions as of Q4 2025.

O
Opaleye·Chicago, IL·Family Office
CIK 0001595855 · last filed Dec 31, 2025
Total AUM
$758M
4.5%
vs prior
Holdings
54
positions
Whale Score
64
64
tracked
Activity
no data
changes this Q
Top sector
Financials
13% weight
concentration
AI Analysis · Q4 2025 · Q4 2025
Comprehensive Analysis of Opaleye Management Inc. SEC 13F Filing
Portfolio Overview

Opaleye Management Inc. manages a concentrated portfolio totaling approximately $425.45 million as of the report date September 30, 2025. The firm employs a high-conviction investment strategy, holding a relatively small number of positions (32) compared to the broader institutional landscape. The portfolio experienced significant volatility during the quarter, with total assets under management (AUM) decr...

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight
01
HROW
HARROW HEALTH INC
$191M3.9M25.2%
02
LQDA
LIQUIDIA CORPORATION
$85M2.4M11.2%
03
ETON
ETON PHARMACEUTICALS INC
$48M2.9M6.4%
04
RYTM
RHYTHM PHARMACEUTICALS INC
$35M330K4.7%
05
APGE
APOGEE THERAPEUTICS INC
$29M388K3.9%
06
SNWV
SANUWAVE HEALTH INC
$29M981K3.9%
07
STOK
STOKE THERAPEUTICS INC
$22M695K2.9%
08
OCUL
OCULAR THERAPEUTIX INC
$19M1.6M2.6%
09
M8694L137
SOL GEL TECHNOLOGIES
$19M454K2.5%
10
CGON
CG ONCOLOGY INC
$17M410K2.2%

Filing history

Filing history loading…